Invivyd

Yahoo Finance • yesterday

Does Invivyd’s (IVVD) Index Debut Reveal a Turning Point in Its Biotech Credibility?

Invivyd, Inc. was recently added to both the NASDAQ Biotechnology Index and the S&P Biotechnology Select Industry Index, increasing its presence among publicly traded biotech peers. This twin index inclusion can broaden Invivyd’s exposure... Full story

Yahoo Finance • 4 days ago

Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an investigational vaccine-alternative mono... Full story

Yahoo Finance • last month

Invivyd to Participate at the 8th Annual Evercore Healthcare Conference

NEW HAVEN, Conn., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that management will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025, at 2:35 p... Full story

Yahoo Finance • last month

Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness

VBY329 is designed for the prevention of Respiratory Syncytial Virus (RSV) infections in newborns, infants, and children, and results from Invivyd’s proprietary antibody discovery technology platformVBY329 meets Invivyd’s target profile of... Full story

Yahoo Finance • last month

Invivyd prices $125M stock offering at $2.50 per share

* Invivyd (IVVD [https://seekingalpha.com/symbol/IVVD]) priced [https://seekingalpha.com/pr/20310672-invivyd-announces-pricing-of-125-million-public-offering-of-common-stock-and-pre-funded] an underwritten public offering of 44M shares a... Full story

Yahoo Finance • last month

Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants

NEW HAVEN, Conn., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced the pricing of an underwritten public offering of 44,000,000 shares of its common stock at an offering price of $2.50 per share an... Full story

Yahoo Finance • last month

Invivyd Announces Proposed Public Offering of Common Stock

NEW HAVEN, Conn., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced that it has commenced an underwritten public offering of shares of its common stock. In addition, Invivyd intends to grant the und... Full story

Yahoo Finance • last month

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change UTime Ltd. 897,372,188 0.045 0.035 0.0365 +0.0165 Aspire Biopharma Holdi... Full story

Yahoo Finance • 2 months ago

Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights

PEMGARDA® (pemivibart) net product revenue of $13.1 million reported for Q3 2025, representing 41% growth year-over-year and 11% growth quarter-over-quarterOctober 2025 ending cash and cash equivalents of over $100 million; ended Q3 2025 w... Full story

Yahoo Finance • 2 months ago

Invivyd to Host Webcast on the REVOLUTION Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

NEW HAVEN, Conn., Oct. 28, 2025 (GLOBE NEWSWIRE) -- WHAT: Invivyd, Inc. (Nasdaq: IVVD) is hosting the previously announced live webcast to present an overview of the company’s REVOLUTION clinical program, Invivyd’s development program f... Full story

Yahoo Finance • 3 months ago

Invivyd Gets FDA Clearance To Start Clinical Trials For COVID-19 Antibody VYD2311

(RTTNews) - Invivyd, Inc. (IVVD) Monday announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for VYD2311, a vaccine alternative antibody candidate for the preventi... Full story

Yahoo Finance • 3 months ago

Invivyd Announces U.S. IND Clearance and Alignment with U.S. FDA on Pivotal Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

The DECLARATION (safety and efficacy vs. placebo) and LIBERTY (exploratory safety head-to-head and combination with mRNA-based COVID vaccination) clinical trials are expected to begin around year-end 2025; top-line data anticipated mid-202... Full story

Yahoo Finance • 3 months ago

Invivyd Appoints Paul B. Bolno, M.D. to Its Board of Directors

NEW HAVEN, Conn., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (NASDAQ: IVVD) today announced the appointment of Paul B. Bolno, M.D., to its Board of Directors and as a member of the Compensation Committee. Dr. Bolno is the President... Full story

Yahoo Finance • 3 months ago

Invivyd Announces Appointment of Kristie Kuhl as Chief Communications Officer

NEW HAVEN, Conn., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced the appointment of Kristie Kuhl as Chief Communications Officer. Ms. Kuhl will lead the Company’s communications and patient advocacy effor... Full story

Yahoo Finance • 3 months ago

These stocks are moving in today's after hours session

After the closing bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. [postmarket] GAINERS TICKER CHANGE COMMENT CHEK [https://www.chartmill.com/stock/... Full story

Yahoo Finance • 4 months ago

SPEAR Study Group to Present its Recommended Long COVID Antibody Study Design Featuring Invivyd’s VYD2311 At RECOVER-TLC Workshop September 9-10, 2025

SPEAR proposal reflects current evidence on monoclonal antibodies in treatment for Long COVID and identifies VYD2311 as a promising next-generation candidate for the clinical study Recommendation is for a robust, comprehensive, translation... Full story

Yahoo Finance • 4 months ago

Top gaining Russell 2000 stocks as index close to strongest performance vs. large-caps

[Small Cap write on sticky notes isolated on Office Desk. Stock market concept] syahrir maulana/iStock via Getty Images The Russell 2000 (IMW) is close to its strongest relative performance compared to the S&P 500 (SP500 [https://seekinga... Full story

Yahoo Finance • 4 months ago

Which stocks have an unusual volume on Thursday?

Discover the stocks with unexpected trading volume in today's session on the US markets. [unusualvolume] TODAY'S UNUSUAL VOLUME STOCKS TICKER CHANGE COMMENT EEIQ [https://www.chartmill.com/stock/quote/EEIQ/profile] 4.9% E... Full story

Yahoo Finance • 4 months ago

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT STSSW [https://www.chartmill.com/stock/quote/STSSW/profile] 86.83%... Full story

Yahoo Finance • 4 months ago

These stocks have an unusual volume in today's session

Unusual volume stocks are being observed in Wednesday's session. [unusualvolume] TOP UNUSUAL VOLUME STOCKS TICKER CHANGE COMMENT INHD [https://www.chartmill.com/stock/quote/INHD/profile] 31.57% INNO HOLDINGS INC (NASDAQ:I... Full story